The clinical outcome (ventricular remodeling) of the patients was analyzed through logistics regression to explore the effects of taking dapagliflozin, taking ACEI/ARB, taking β-block, LVEDV, LVEF, BNP, NLR, Hb1AC, history of diabetes, uric acid, and CnTI on admission on the prognosis. This evidence concerns the gene NPPB and diabetes mellitus.